Huntington National Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Buy
78,113
+18,255
+30% +$2.56M 0.06% 209
2025
Q4
$7.35M Buy
59,858
+514
+0.9% +$62.5K 0.04% 213
2025
Q3
$6.59M Buy
59,344
+657
+1% +$74.7K 0.04% 229
2025
Q2
$6.51M Buy
58,687
+871
+2% +$92.7K 0.04% 226
2025
Q1
$6.48M Buy
57,816
+476
+0.8% +$49.1K 0.05% 223
2024
Q4
$5.3M Sell
57,340
-921
-2% -$82.9K 0.04% 239
2024
Q3
$4.88M Sell
58,261
-11
-0% -$839 0.04% 247
2024
Q2
$4M Sell
58,272
-537
-0.9% -$35.8K 0.03% 261
2024
Q1
$4.31M Sell
58,809
-1,553
-3% -$119K 0.03% 253
2023
Q4
$4.89M Sell
60,362
-1,812
-3% -$141K 0.04% 238
2023
Q3
$4.66M Buy
62,174
+152
+0.2% +$11.7K 0.05% 235
2023
Q2
$4.78M Sell
62,022
-2,121
-3% -$169K 0.04% 236
2023
Q1
$5.32M Sell
64,143
-3,908
-6% -$324K 0.05% 226
2022
Q4
$5.84M Sell
68,051
-6,536
-9% -$518K 0.06% 221
2022
Q3
$4.6M Sell
74,587
-2,376
-3% -$150K 0.05% 231
2022
Q2
$4.76M Sell
76,963
-2,258
-3% -$140K 0.05% 231
2022
Q1
$4.71M Sell
79,221
-2,609
-3% -$167K 0.04% 242
2021
Q4
$5.94M Sell
81,830
-4,574
-5% -$315K 0.05% 227
2021
Q3
$6.04M Sell
86,404
-4,620
-5% -$325K 0.06% 217
2021
Q2
$6.27M Buy
91,024
+16,259
+22% +$1.09M 0.06% 214
2021
Q1
$4.83M Sell
74,765
-2,234
-3% -$144K 0.06% 206
2020
Q4
$4.49M Sell
76,999
-1,782
-2% -$108K 0.06% 197
2020
Q3
$4.98M Sell
78,781
-2,955
-4% -$205K 0.07% 183
2020
Q2
$6.29M Buy
81,736
+2,528
+3% +$194K 0.1% 156
2020
Q1
$5.92M Sell
79,208
-4,924
-6% -$340K 0.11% 159
2019
Q4
$5.47M Sell
84,132
-3,357
-4% -$219K 0.08% 182
2019
Q3
$5.54M Sell
87,489
-7,997
-8% -$523K 0.09% 179
2019
Q2
$6.45M Sell
95,486
-15,456
-14% -$1.02M 0.1% 167
2019
Q1
$7.21M Sell
110,942
-13,677
-11% -$909K 0.12% 158
2018
Q4
$7.79M Sell
124,619
-20,754
-14% -$1.45M 0.14% 154
2018
Q3
$11.2M Sell
145,373
-23,595
-14% -$1.78M 0.18% 142
2018
Q2
$12M Sell
168,968
-37,053
-18% -$2.62M 0.2% 137
2018
Q1
$15.5M Sell
206,021
-6,324
-3% -$503K 0.26% 117
2017
Q4
$15.2M Buy
212,345
+1,578
+0.7% +$120K 0.24% 120
2017
Q3
$17.1M Sell
210,767
-352
-0.2% -$26.9K 0.29% 114
2017
Q2
$14.9M Sell
211,119
-12,831
-6% -$854K 0.26% 119
2017
Q1
$15.2M Sell
223,950
-19,791
-8% -$1.39M 0.27% 117
2016
Q4
$17.5M Sell
243,741
-13,398
-5% -$996K 0.32% 98
2016
Q3
$20.3M Sell
257,139
-5,273
-2% -$428K 0.38% 90
2016
Q2
$21.9M Sell
262,412
-86,574
-25% -$7.68M 0.55% 57
2016
Q1
$34.2M Buy
348,986
+1,440
+0.4% +$130K 0.84% 24
2015
Q4
$35.2M Sell
347,546
-7,070
-2% -$736K 0.89% 20
2015
Q3
$34.8M Sell
354,616
-5,814
-2% -$646K 0.91% 21
2015
Q2
$42.2M Buy
360,430
+14,004
+4% +$1.53M 1.02% 15
2015
Q1
$34M Sell
346,426
-15,899
-4% -$1.61M 0.83% 24
2014
Q4
$34.2M Sell
362,325
-36,833
-9% -$3.81M 0.82% 26
2014
Q3
$42.5M Buy
399,158
+295
+0.1% +$28.9K 0.87% 17
2014
Q2
$33.1M Sell
398,863
-15,859
-4% -$1.23M 0.65% 31
2014
Q1
$29.4M Buy
414,722
+26,074
+7% +$2.04M 0.56% 35
2013
Q4
$29.2M Buy
388,648
+3,501
+0.9% +$244K 0.77% 26
2013
Q3
$24.2M Buy
385,147
+18,169
+5% +$1.09M 0.72% 30
2013
Q2
$18.8M Buy
+366,978
New +$19.1M 0.59% 43

Other funds holding GILD

Huntington National Bank's GILD Position: Q1 2026 in Review

Huntington National Bank increased its Gilead Sciences (GILD) stake by 30% in Q1 2026, buying an estimated $2.56M and bringing the position to 78,113 shares worth $10.9M. The position accounts for 0.06% of the portfolio, ranked #209.

Huntington National Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $42.5M in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Huntington National Bank held 78,113 shares of Gilead Sciences worth $10.9M as of Q1 2026.
  • Huntington National Bank bought 18,255 Gilead Sciences shares in Q1 2026, an estimated $2.56M.
  • Gilead Sciences made up 0.06% of Huntington National Bank's portfolio in Q1 2026, its #209 holding.
  • Huntington National Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Huntington National Bank's Gilead Sciences position peaked at $42.5M in Q3 2014.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.